Curcumin Inhibits Transforming Growth Factor-Beta Activity Via Inhibition of Smad Signaling in HK-2 Cells.

Ying Hu,Hua Liang,Yong Du,Yongliang Zhu,Xuanding Wang
DOI: https://doi.org/10.1159/000287230
2010-01-01
American Journal of Nephrology
Abstract:Background: Curcumin, a polyphenolic compound derived from rhizomes of Curcuma spp., has been shown to possess potent anti-fibrotic properties. Here, we investigate the role of curcumin in modulating the profibrotic action of TGF-beta in human proximal tubule cells (HK-2) and its underlying mechanisms. Methods: HK-2 cells were stimulated with 5 ng/ml TGF-beta 1. The effects of curcumin on TGF-beta 1-regulated gene expression and Smad phosphorylation were analyzed by RTPCR, ELISA and Western blotting. Results: Curcumin inhibited TGF-beta 1 -induced plasminogen activator inhibitor-1 (PAI-1), alpha-smooth muscle actin (alpha-SMA) mRNA and protein expression. Curcumin suppressed not only TGF-beta 1-induced Smad2 phosphorylation in a dose-and time-dependent manner, but also the nuclear accumulation of receptor-regulated Smads (R-Smad), Smad2 and Smad3. A serine/threonine protein phosphatase inhibitor (microcystin) could partly reverse the inhibitory effect of curcumin on Smad phosphorylation. Conclusions: Curcumin blocks the profibrotic actions of TGF-beta on HK-2 cells through the down-regulation of the Smad signaling pathway, and curcumin may have some similar effect as serine/threonine protein phosphatases. Our findings suggest curcumin as a potential candidate for treatment of tubulointerstitial fibrosis. Copyright (C) 2010 S. Karger AG, Basel
What problem does this paper attempt to address?